The level of specialist assessment of adult asthma is influenced by patient age  by Porsbjerg, C. et al.
Respiratory Medicine (2014) 108, 1453e1459Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.elsevier .com/locate/rmedThe level of specialist assessment of adult
asthma is influenced by patient age
C. Porsbjerg*, A. Sverrild, L. Stensen, V. BackerRespiratosry Research Unit, Department of Respiratory Medicine, Bispebjerg University Hospital,
Copenhagen, DenmarkReceived 11 May 2014; accepted 7 July 2014
Available online 18 July 2014KEYWORDS
Asthma;
Ageing;
Clinical
epidemiology;
Respiratory
measurement;
Exhaled airway
markersAbbreviations: FeNO, fraction of ex
responsiveness; PRF, patient record fo
* Corresponding author. Respiratory
23, 2400 Copenhagen NV, Denmark. T
E-mail address: porsbjerg@dadlnet
http://dx.doi.org/10.1016/j.rmed.201
0954-6111/ª 2014 Elsevier Ltd. All rigSummary
Background: Late onset asthma is associated with more severe disease and higher morbidity
than in younger asthma patients. This may in part relate to under recognition of asthma in old-
er adults, but evidence on the impact of patient age on diagnostic assessment of asthma in a
specialist setting is sparse.
Aim: To examine the impact of patient age on the type and proportion of diagnostic tests per-
formed in patients undergoing specialist assessment for asthma.
Methods: Data from a clinical population consisting of all patients consecutively referred over
a 12 months period to a specialist clinic for assessment of asthma were analysed.
Results: A total of 224 patients with asthma or suspected asthma were referred during the 12
month period; 86 adults aged <35 years, 95 aged 35e55 years and 43 aged >55 years. Symptom
characteristics were similar, but adults >35 years had a lower lung function than younger
adults, and were more frequently smokers. However, a regression analysis showed that older
age was associated with a lower likelihood of diagnostic assessment with a reversibility test, a
bronchial challenge test, or measurement of exhaled NO, independently of a known diagnosis
of asthma, smoking habits and lung function at referral.
Conclusion: A lower level of diagnostic assessment was observed already after the age of 35
years, indicating a risk for under diagnosis of asthma at an earlier patient age than previously
thought.
ª 2014 Elsevier Ltd. All rights reserved.haled nitric oxide; SABA, short-acting beta-2-agonist; SPT, skin prick test; AHR, airway hyper-
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Diagnostic assessment of asthma is the starting point of
asthma management: International Guidelines recommend
that a diagnosis of asthma is based on symptom history
combined with objective measures of variable airflow
obstruction, e.g. reversibility to beta-2-agonist, peak flow
variability or airway hyperresponsiveness [1,2]. The next
step is to assess asthma control to determine the need for
commencing treatment, and a baseline assessment from
which the effect of treatment may be determined [1].
In patients with known asthma and insufficiently
controlled asthma symptoms, obtaining objective disease
evidence may furthermore be important, to differentiate
asthma symptoms from non-specific symptoms that may
relate to other factors such as poor fitness or hyperventi-
lation. Finally, measurement of markers of the asthma
phenotype, such as allergic sensitisation or eosinophilic
airway inflammation, may aid in targeting treatment to the
individual patient [3e5].
Under diagnosis of asthma, and under recognition of the
severity of asthma, has significant adverse impact on the
treatment of asthma: In a Danish population sample of
10,877 adults aged 18e44 years, only 50% of asthma cases
had previously been diagnosed, and among the previously
undiagnosed cases, 74% had persistent symptoms (>2/
week) indicating a significant unmet need for treatment
[6].
Older asthma patients have a higher morbidity than
younger asthma patients, in terms of a lower lung function
and more severe exacerbations [7e10]. This may in part
relate to an under recognition of asthma by physicians as
well as patients [11e14]: In a community sample of 4581
persons >65 years old from the Cardiovascular Health
Study, only half of those with asthma like symptoms had a
previous diagnosis of asthma [11]. Similarly, in a retro-
spective study of 98 individuals with asthma onset after the
age of 65 years, only 43% had a spirometry performed in
relation to having the diagnosis made [14].
However, there is limited evidence of whether special-
ists assess asthma in older adults differently to younger
adults within the same clinical setting. Given that late
onset asthma is generally reported to be associated with
irreversible airflow obstruction [14,15], clinicians could be
less likely to test older adults for reversibility or airway
hyperresponsiveness. Furthermore, since that late onset
asthma is more often non-atopic [16,17], it may be that the
use of additional diagnostic tests to aid in a phenotypic
characterisation of asthma, such as measurement of
exhaled nitric oxide (FeNO) and skin prick testing for al-
lergy is used less frequently in the older patients. Finally, it
is unclear whether specialists have a different approach to
adult asthma patients already earlier on, i.e. after the age
of 35e40 years.
We hypothesized that in a specialist clinic, the level of
diagnostic assessment of adult asthma is influenced by
patient age. Hence, we compared the number and type of
diagnostics tests performed in a clinical cohort of patients
consecutively referred for assessment of asthma over a 12
month period, and compared young, middle aged and older
adults.Methods
A complete population of all patients consecutively
referred to a specialist asthma clinic for either suspected or
known asthma, over a 12 months period in 2010, were
studied at the outpatient clinic at the Department of Res-
piratory Medicine at Bispebjerg University Hospital,
Copenhagen, Denmark. A retrospective design was pur-
posefully chosen to avoid observer bias, as the outcome of
interest was the pattern of specialist assessment of older
versus younger adults.
Data was obtained from patient record forms (PRF),
including physician notes on asthma symptoms, including
characterisation of symptoms, asthma medications used
and diagnostic tests requested. The study was approved by
the Danish National Health Board (Jr Nr 7-604-04-2/279/
KWH), as this retrospective study did not require approval
from the Ethics Committee.
The following was registered, regarding the level of
diagnostic assessment:
Symptoms:
 Symptoms assessed: Did the physician record the
following asthma symptoms at rest and during exercise:
Shortness of breath, tightness of the chest, wheezing
and cough?
 Symptoms reported: If recorded, did the patient report
any of above asthma symptoms?
Diagnostic tests performed:
 Reversibility of FEV1 to short-acting beta-2-agonist
(SABA)?
 Bronchial challenge with either methacholine or
mannitol?
Additional tests performed:
 Measurement of exhaled nitric oxide (FeNO)?
 Skin prick test (SPT) to a standard panel of inhalation
allergens.Description of the diagnostic methods
 Spirometry (Jaeger MasterSceen Pneumo spirometer,
CareFusion, Yorba Linda, CA): best of two measurements
of FEV1, FVC and FEV1/FVC ratio according to ERS rec-
ommendations [18]. Reversibility test 20 min after
inhalation with terbutaline sulphate (1.5 mg).
 Exhaled NO (FeNO) (NIOX, Intra Medic, Denmark)
average of 3 measurements (flow rate 50 ml) was
measured according to the ATS/ERS guidelines [19].
 Mannitol provocation test (osmohale Mannitol, phar-
maxis, UK): inhalation of ascending dosages 0, 5, 10, 20,
40, 80, 160, 160, 160 mg [20]. A positive test was defined
as a 15% fall in FEV1 or more and resulted in termination
of test.
 Methacholine provocation test with the Yan method
(Jaeger device, nebulised fluid: methacholine bromide):
Inhalation of isotonic saline, thereafter five successively
Impact of age on specialist assesment of asthma 1455increasing doses of methacholine ranging from 0.06 to
8 mmol were delivered, until a cumulated dose of 8 mmol
or a 20% decrease in FEV1 was reached [21]. Measure-
ments of FEV1 exactly 1 min after inhalation. A 20% fall
in FEV1 or more was defined as a positive result and
terminated the test.
 A skin prick test to 10 aeroallergens (birch [Betula spe-
cies], grass [Phleumpratense] mugwort, horse, dog, cat
[Felis domesticus], house dust mite [Der p1 and Der f2],
and fungi [Alternaria and Cladosporium species; ALK-
Abello, Hoersholm, Denmark]) according to the EAACI
recommendations [22]. Allergic sensitization was
defined as a positive skin prick test response to at least 1
of these 10 aeroallergens.Statistical analysis
Patients were divided into three groups, in order to eval-
uate how the pattern of diagnostic testing changed with
increasing age: Young adults: age <35 years, middle aged
adults: age 35e55 years, and older adults: age >55 years at
the time of referral.
Patient characteristics were compared for the three age
groups using chi-square tests for categorical variables and
anova for continuous variables. Pair-wise comparisons were
subsequently made with chi-square test and non-paired t-
tests.
As the proportion of patients with known asthma at
referral did not differ between the three age groups, data
was analysed without a separation of patients with sus-
pected and known asthma at referral. Known asthma was
defined a patient reported previous doctors diagnosis of
asthma.
The proportion of patients within the three age groups
who had a diagnostic test was compared, using a Chi2 test.
Furthermore, a backward regression analysis was per-
formed to determine whether the effect of patient age on
the diagnostic tests performed was independent of other
potential explanatory variables (smoking status, airflowTable 1 Patient characteristics in 224 patients referred for spe
<35 Years (n Z 86) 3
Age (years, median (minemax)) 24 (15e34) 4
Gender (female) 54.7% 5
BMI (mean (SD)) 23.2 (3.6) 2
Smoker 12.0% 1
Ex-smoker 6.2% 1
Known asthma at referala 44.0% 4
ICS 19.7% 2
ICS þ LABA 22.1% 2
FEV1% (mean (SD)) 92.3 (16.6) 8
FVC% (mean (SD)) 98.1 (17.1) 9
FEV1/FVC% (mean (SD)) 0.80 (0.11) 0
FEV1 < 80% of predicted (% (n)) 19.7% (15)
b,* 3
*p < 0.05.
**p < 0.001.
a Previous diagnosis of asthma at the time of referal.
b Comparison with young age group (<35 years).obstruction (FEV1 < 80%), known asthma at referral and
symptoms of allergic rhinoconjuctivitis).
Data was analysed with SPSS version 20.0 (SPSS, Inc,
Chicago, Ill).Results
The characteristics of the 224 patients referred to the
specialist clinic during 2010 are summarised in Table 1, for
the three age groups (<35 years, 35e55 years and >55
years). The proportion of patients who, according to the
referring physician, had known asthma at the time of
referral was the same in the three age groups (44%, 40% and
42%, NS). The FEV1% as well as the FEV1/FVC% of predicted
was lower in the two older age groups compared to the
youngest group, and accordingly a significantly higher pro-
portion of patients with reduced FEV1 (FEV < 80% of pre-
dicted: 20%, 40% and 53% respectively).
In spite of the lower lung function, the use of regular
anti-inflammatory medications was similar in the three
groups, with 42% of young adults, 48% of adults aged 35e55
years, and 45% of adults >55 years using either ICS or an
ICS þ LABA (ns)(Table 1).
A previous smoking history was more common in the
older age groups, with approximately half of adults >55
years being either current or previous smokers (Table 1).
The diagnosis recorded in the PRF by the specialist was
compared for the three age groups: After the specialist
assessment, older adults were less likely to receive a final
diagnosis of asthma than younger adults (23% in adults >55
years vs 54% in adults aged 35e55 years and 59% in <3 year
olds, p < 0.001).
Symptom assessment recorded in the PRF showed that
symptoms at rest were assessed for a similar proportion of
patients in the three age groups (Fig. 1). Furthermore, the
symptoms reported were similar, except for cough and
phlegm production, which were more frequently reported
in adults aged 35e55 years vs adults <35 years (Cough: 47%
vs 25%, p < 0.05. Phlegm production: 7.9% vs 18.4%,cialist assessment of asthma.
5e55 Years (n Z 95) >55 Years (n Z 43) p
4 (35e54) 64 (55e82) <0.001
5.8% 67.4% 0.34
6.3 (4.5) 26.1 (4.2) <0.001
4.9% 20.9% 0.69
7.6%b,* 27.5%b,* 0.009
0.4% 41.9% 0.89
1.0% 14.9% 0.44
7.3% 30.2% 0.64
5.5 (21.5)b,* 76.2 (24.0)b,** <0.001
3.2 (22.3) 83.8 (18.5)b,** 0.003
.75 (0.10) 0.71(0.14) 0.001
9.5% (32) 52.5% (21)b,** 0.001
Table 3 Backward regression analysis of predictors of
diagnostic tests performed.
OR C.I. p
Reversibility to SABA
Age groupa 0.62 0.41e0.95 0.03
Current smoker 0.92 0.84e0.99 0.04
FEV1 < 80% of predicted 1.82 0.93e3.57 0.08
Known asthma at referal 0.77 0.57e1.03 0.08
Bronchial challengeb
Age groupa 0.62 0.40e0.95 0.03
Current smoker 0.93 0.85e1.01 0.08
FEV1<80% of predicted 0.37 0.19e0.73 0.004
Known asthma at referal 0.74 0.52e1.06 0.11
FeNO
Age groupa 0.59 0.38e0.90 0.01
Current smoker 0.90 0.83e0.98 0.02
Skin prick test performedc
Age groupa 0.65 0.42e1.02 0.06
Current smoker 0.92 0.84e0.99 0.04
FEV1 < 80% of predicted 0.57 0.29e1.10 0.09
Symptoms of allergic
rhinoconjuctivitis
0.93 0.85e1.01 0.08
a Age group: <35 years, 35e54 years, >55 years.
b Bronchial challenge with methacholine or mannitol.
c Panel of ten aeroallergens (grass, birch mugwort, cat,dog,-
horse, derm P, derm F, cladosporium, alternaria).
1456 C. Porsbjerg et al.p < 0.01). Only one subject, aged >55 years, reported
chronic mucus secretion (i.e. cough and phlegm for more
than three months, two years in a row). Smokers had more
cough than non-smokers (58.6% vs 34.8%, p < 0.05), but
similar frequencies of other respiratory symptoms.
In comparison, symptoms during exercise were more
frequently assessed in the youngest age group (shortness of
breath, tightness of the chest and wheezing (Fig. 1(A)), and
this group also reported more exercise related symptoms
(Fig. 1(B))).
The degree of diagnostic assessment differed between
the three age groups: Although patients >35 years more
often had a reduced lung function, a similar number had a
reversibility test performed (Table 2). Bronchial challenge
testing was performed more often in the youngest age
group, which was in keeping with the majority of this group
having a normal lung function. On the other hand, 78% of
35e55 year olds, and 60% of the >55 year olds had a lung
function that allowed for a bronchial challenge
(FEV1 > 70%). Overall, the number of diagnostic tests was
higher in the younger age group, with only few older adults
having more than one test performed (Table 2).
In order to adjust for the confounding effect of the
lower lung function and higher smoking history in older
adults, a regression analysis was performed. This showed
that older age was independently associated with a lower
likelihood of having a reversibility test performed, or a
bronchial challenge (Table 3). Similarly, older age was
associated with a lower likelihood of having additional
testing with measurement of FeNO, as well as skin prick
testing performed (Table 3).
When comparing the test results for those patients in
each age group, who did have a test performed, there was
no significant difference in the degree of reversibility or in
the proportion of subjects with a positive bronchial chal-
lenge test (Table 4). Furthermore, the level of FeNO as well
as the proportion of patients with a positive skin prick test
to aeroallergens, was similar in all three age groups, among
those tested (Table 4). Despite the lower number of tests
performed in the oldest age groups, the proportion of
subjects with a positive objective test (reversibility or AHR)
was the same in all three groups; (31%, 36% and 36%, ns).
According to the specialist evaluation, older adults were
more frequently concluded to have COPD or a combination
of COPD and asthma, than younger adults: (Age >55 years:
Asthma: 30.2%, asthma/COPD: 14.0%, COPD: 16.3%. AgeTable 2 Diagnostic tests performed in young, middle aged and
<35 Years (n Z 86)
Reversibility test to SABA performed 54%NS
Bronchial challenge testing performeda 57%
Number of diagnostic tests performed (reversibility or bronchial
0 31%
1 29%
2 40%
FeNO measurement performed 70%
Skin prick test performed 65.1%
*p < 0.05. NS: non-significant, p > 0.05.
a Bronchial challenge with methacholine, mannitol or comparison w<55 years: Asthma 57.2%, asthma/COPD: 2.1%, COPD: 1.2%,
p < 0.001).
Discussion
In this clinical population consisting of all patients referred
consecutively over a 12 months period for assessment of
asthma, we found that commonly objective diagnostic tests
for asthma were applied less frequently in older adults,
already from the age of 35 years, indicating a potential
under diagnosis of asthma from early middle age.
Most studies have described older adults, typically aged
over 55e60 years [12,23], and younger adults [24], and less
is known about how the age group in between is typically
assessed. Adult onset asthma is however common, and it
has recently been found that in females, adult onsetolder adults referred for specialist assessment of asthma.
35e55 Years (n Z 95) >55 Years (n Z 43) p
55%NS 37%NS 0.12
40%* 28%* 0.004
challenge test):
29% 42%
47% 51%
24% 7% 0.001
58% 48%* 0.04
52.1%NS 38.1%* 0.014
ith young age group (<35 years).
Table 4 Proportion of positive testsa in young, middle aged and older adults referred for specialist assessment of asthma.
<35 Years 35e55 Years >55 Years p
Reversibility to SABA >12% (% (n/n)) 18% (8/44) 28% (14/51) 37% (6/16) 0.28
DFEV1 (%) (mean (SD)) 8.4% (7.8) 10.5% (15.5) 10.1% (8.4) 0.68
Bronchial challenge test positiveb(% (n/n)) 44% (19/41) 49% (20/37) 62% (9/13) 0.64
FeNO > 25 ppb (% (n/n)) 21% (12/57) 30% (16/54) 21% (4/19) 0.54
FeNO (ppb) (mean (SD)) 22 (24) 26 (26) 24 (29) 0.69
Skin prick test positive 46% (25/54) 40% (20/50) 38% (6/16) 0.73
a Among patients in whom the test was performed.
b Bronchial challenge with methacholine, mannitol.
Impact of age on specialist assesment of asthma 1457asthma was the most common phenotype [25]. Similarly,
we found that among those referred to the specialist clinic,
there was a similar number of suspected new cases of
asthma in all three age groups, indicating that there is an
equal requirement for diagnostic assessment of potential
asthma across all adult age groups.
Part of the observed differences in diagnostic testing
may relate to a reduced lung function in a large proportion
of the older adults, precluding a bronchial challenge test.
However, the effect of patient age on whether a bronchial
challenge was performed was independent of a reduction in
lung function. Furthermore, most of the older patients in
the present population had an FEV1 > 70%, and could have
had a bronchial provocation test performed. This could
suggest that clinicians have a biased approach to older
patients with possible asthma, and that older patients are
assumed more likely to have COPD rather than asthma,
regardless of their smoking exposure.
At the same time, given the higher degree of airflow
obstruction among older patients, it is surprising that a low
proportion had a reversibility test performed. Interestingly,
the degree of reversibility in those tested was similar in the
three age groups, indicating a similar ability of the airways
to dilate in spite of a lower FEV1 in the older patients.
We found that a similar proportion of patients in the
three age groups had at least one positive diagnostic test,
which could suggest that further tests were not deemed
necessary in the older age group. Our results also indicate
that younger adults had milder disease, hence requiring
more tests before the diagnosis could be confirmed. On the
other hand, a total of 42% of the oldest age group did not
have a reversibility test or a bronchial challenge, and hence
a substantial proportion of the older patients were not
tested for variable airflow obstruction.
Under diagnosis of asthma is common in older adults [11]
and may relate to under perception by patients, who do not
seek their GP [26,27], as well as to a lack of diagnostic
testing by the physician. Param et al. found that within a
community sample of 1362 individuals, only 21 out of 95
older adults with asthma received regular ICS treatment,
despite significant symptoms and airflow obstruction [12].
Symptoms of asthma are often non-specific in that
other conditions such as COPD and chronic bronchitis as
well as heart failure may result in similar symptoms.
Hence, confirming a suspicion of asthma with an objective
diagnostic test is of particular importance in older adults
[28]. The lower lung function in late onset asthma could
lead to misclassification as COPD. This could lead to undertreatment or erroneous treatment, such as the use of
LABA monotherapy. As older adults have a more severe
asthma, they furthermore represent a group of patient in
whom a higher level of diagnostic awareness should be
present. Specifically, asthma patients with airflow
obstruction and asthma/COPD overlap syndrome have
been shown to have a significantly better prognosis than
COPD patients [29].
Symptom characteristics did however not differ signifi-
cantly between the three age groups, apart from cough
being more frequent in older adults. Furthermore, symp-
toms in relation to exercise were not recorded as often in
older adults, suggesting a degree of under assessment of
symptoms.
Older adults were also more often smokers or ex-
smokers, which could also influence the pattern of diag-
nostic testing. However, the effect of age was not
explained by the patient’s smoking habits, as it was inde-
pendent of the effect of smoking in the regression analysis.
Measurement of FeNO and SPT to aeroallergens may be
used to characterise asthma, and predict effect of specific
therapies such as ICS [4,5]. They were performed less often
in older patients, which may relate to assumptions
regarding the inflammatory phenotype in older asthma
patients. The percentage of sputum eosinophils in older
asthma patients is however similar to younger patients [30],
and, eosinophilic airway inflammation is also a driver of
airway hyperresponsiveness in asthma in older adults [31].
Assessing markers of eosinophilic airway inflammation is
therefore equally relevant in the older asthma patient. We
found that in those who were tested, the level of FeNO and
the proportion of atopic individuals were similar in older
and younger patients.
In conclusion, in a clinical population of adults referred
for asthma assessment in a specialist setting, the level of
diagnostic evaluation decreased already from the age of 35
years, with the lowest proportion of diagnostic testing in
the oldest age group. This may have significant negative
implications for the management of asthma in middle aged
and older adults.Contributor statement
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